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Summary: Two clinical observations indicate that the kidney plays the main role in the elimination of lipase
and amylase from the circulation:
1. in patients with uncomplicated acute pancreatitis the decrease of the activity of both enzymes in the serum
ran almost in parallel. The half life for lipase was found to be 6.9 —13.7h, and somewhat higher figures
(9.3 — 17.7 h) were calculated for amylase;
2. in patients with reduced glomerular filtration rate the serum activity of either or of both enzymes was
distinctly elevated.
The contribution of the kidney to the elimination of lipase and amylase from blood was studied in the rat.
After an intravenous bolus injection of homologous lipase and amylase, the serum activity of both enzymes
decreased rapidly. The half-life öf lipase was 18.1 min, that of amylase 20.5 min. Up to 30% of the injected
amylase but only traces of lipase activity were recovered in the urine. In animals with ligated kidneys the
serum half-life of both enzymes was 3 times longer.
Our results indicate that lipase äs well äs amylase are removed from the serum mainly by glomerular filtration
at nearly the same rate. Reabsorption of lipase is almost complete, in contrast to that of amylase. It is
suggested that the differences in the renal handling of both enzymes are due to their differing affinities for
hydrophilic and hydrophobic surfaces.
Die Bedeutung der Niere fär die Ausscheidung von Pankreaslipase und -amylase aus dem Blut
Zusammenfassung: Zwei klinische Beobachtungen deuten darauf hin, daß der Niere die Hauptrolle bei der
Elimination von Lipase und Amylase aus der Zirkulation zukommt.
l/ Bei Patienten mit unkomplizierter akuter Pankreatitis findet sich ein parallel verlaufender Abfall beider
Enzymaktivitäten. Die Halbwertszeit für die Lipase liegt zwischen 6,9 bis 13,7h, für die Amylase ergaben
sich etwas höhere Werte mit 9,3 bis 17,7 h.
2. Die Mehrzahl von Patienten mit deutlich eingeschänkter glomerulärer Filtrationsrate hatte erhöhte
Serumaktivitäten beider oder eines von beiden Enzymen.
Tierexperimentell wurde die Rolle der Niere bei der Ausscheidung von Lipase und Amylase aus dem
Blutkreislauf an Ratten näher untersucht. Nach einer intravenösen Bolus-Injektion der beiden homologen
J) Excerpts of this paper have been presented to the 5th European Congress of Clinical Chemistry, Budapest, 1983.
i
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Enzyme fand sich ein rascher Abfall der Enzymaktivitäten mit einer Halbwertszeit von 18,1 min für die
Lipase und von 20,5 min für die Amylase. Während von der gegebenen Amylasedosis etwa 30% in aktiver
Form im Urin erschien, ließen sich von der Lipase nur initial Spuren nachweisen. Bei Tieren mit abgebundenen
Nieren ergaben sich um den Faktor 3 längere Halbwertszeiten für beide Enzyme.
Unsere Ergebnisse zeigen, daß Lipase und Amylase in etwa gleichem Ausmaß durch glomeruläre Filtration
aus der Zirkulation ausgeschieden werden, daß Lipase aber im Gegensatz zu Amylase? praktisch vollständig
von der Niere rückresorbiert wird. Dieser Unterschied in der renalen Behandlung beider Enzyme könnte mit
deren unterschiedlicher Affinität zu hydrophilen bzw. hydrophoben Oberflächen zusammenhängen.
Introduction
The fate of proteins released into the circulation —
irrespective of whether they are secreted or liberated
from injured cells — is to a large extent unknown
(for review see 1. c. (1)). The mechanism of removal
is clarified only for small proteins (Afr 60 000). These
are more or less quantitatively eliminated from the
blood by glomerular filtration, äs shown, for exam-
ple, for polypeptide hormones or free light chains of
immunoglobulins in myeloma. The same seems also
to apply to amylase (MT 54000). Shortly after the
onset of an acute pancreatic disorder, active amylase
appears in the urine. Measurement of urinary amylase
activity is therefore a valuable tool for the laboratory
diagnosis and monitoring of pancreatitis. In healthy
subjects clearance of amylase amounts to about 2%
of the creatinine clearance, but in acute pancreatitis
it may even reach 10 — 15%.
In contrast to amylase, little is known about the
elimination of pancreatic lipase from the circulation.
This enzyme has an even smaller molecular weight
than amylase (MT 48000), thus it could be expected
to be filtered in the kidney. However, reports con-
cerning the detection of lipase activity in the urine
are contradictory (2, 3, 4). Traces of the enzyme have
been detected in urine by an immunological technique
but only in amounts masked by the physiological
proteinuria (5).
While the exact knowledge of the mechanism of elim-
ination of intravascular enzymes is of little diagnostic
relevance, the knowledge of the rate of their dis-
appearance is important: a delayed fall of the serum
activity indicates persistence or even progress of a
pathological process. The half lives of most of the
diagnostically useful enzymes have been empirically
determined in patients with a severe, short-lasting
tissue injury. However, reliable data for amylase
obtained in this way are scarce: Nord et al. found a
half-life of 10 h for amylase in man after intravenous
administration of the enzyme (6). For lipase there is
only one single clinical observation available which
shows a half-life of 15 h (7).
It was therefore the aim of the present study to
determine
a) the half-life for both pancreatic lipase and amylase,
and
b) to elucidate the role of the kidneys in the elim-
ination of these enzymes.
Our study was carried out in patients with
uncomplicated acute pancreatitis without impaired
renal function äs well äs in patients without
pancreatic disorders but suffering from severe renal
insufficiency. Furthermore, in order tö study the im-
mediate effect of the kidney on the elimination of
lipase and amylase, experiments employing purified
amylase and lipase were performed in healthy rats.
Materials and Methods
Patients ' ~
Several subjects were selected from a group of more than a
hundred patients adrriitted to our hospital with acute
pancreatitis. They had in common very high initial serum lipase
and amylase activities, and were therefore clpsely monitored:
routine laboratory parameters and serum enzyme activities were
checked at least every 12 hours. The seeond group studied
consisted of patients maintained on haemodialysis due to
chronic renal insufficiency. They had no known pancreatic
disorders.
Animal experiments
Albino Wistar rats of 200— 300 g body weight maintained on
normal laboratory chow (Altromin 1321 R) were used. The
animals were narcotized with pentqbarbital (Nembutäl®) (40
mg/kg body weight) injected intraperitoneailly. As described
previously (8), a polyethylene catheter was placed into one
of the external jugular veins and a continuous infusion of
physiological saline was started (1.2 ml per hour) in order to
secure sufficient diuresis. This was foliowed by opening the
abdomen by a mid-line iricision arid cannulation of both ureters
with polyethylene catheters (Intramedic f E 10, Ciay Adams,
USA). The abdomen was closed by 2—3 sutures. After 30 min,
rat pancreatic extract (see below) was adininistered in a single
dose through the venous catheter. In several experiments this
dose also contained [14C] labelled inulin. Soine of the animais
received a continuous inulin infusion in order to check the
glomerular filtration rate (GFR). % J
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In experiments on nephrectomized animals the kidneys were
ligated prior to the injection of the pancreatic extract. These
animals received no continuous Infusion.
Blood samples (60 μΐ) were collected from the tail every 10 min,
starting 5 min after injection. Sampling was carried out for 120
min.
Urine samples were collected from both kidneys. The sampling
periods varied between 10 and 30 min, according to the diuresis.
At the end of the collecting period the abdomen was reopened
and the animal was exsanguinated by drawing blood from the
abdominal aorta.
Preparat ive methods
Rat pancreatic extract was obtained s follows: pancreatic
tissue was homogenized with an Ultraturrax homogenizer
(Janke and Kunkel, FRG) at top speed for 2 min in a twenty-
fold volume of distilled water containing soy-bean trypsin in-
hibitor (l g/l). To the homogenate an equal volume of Frigen®
(tri-chloro-tri-fluoro-ethane) was added. After thorough (end
over end) mixing for 10 min the preparation was centrifuged
at 8000g. The clear supernatant was lyophilized and re-
suspended in 0.15 mol/1 NaCi so that l ml of the Suspension
corresponded to the extract of l g tissue. After dialysis against
0.15 mol/1 NaCl for 2 h the preparation was frozen at -20 °C.
Lipase activity of the preparation exceeded 750 000 U/l, amylase
activity250000U/l.
Analytical methods
Measurement of the lipase catalytic activity of all samples
was carried out using a Boehringer kit (Monotest® Lipase No
159697) without modification (turbidimetric method). For the
determination of amylase activity the continuous UV test of
Biomed, FRG employing maltotetraose s Substrate (Monamyl-
neu) was used. Creatinine was determined by the Jaffe reaction
using an Auto Analyzer II. Activity of [14C]inulin was measured
in a liquid scintillation spectrometer (Packard Tri-Carb 300
CD).
Calculations
Biological half-life (t1/!) f r all substances tested was calculated
from the blood samples by Computing the least squares linear
regressipn. For better comparison the injected activity was set
at 100% in every experiment. Symbols in the respective figures
repfesent the mean value (x) and the Standard deviation (SD)
f f each sampling period. The renal clearance (C) of [14C]inulin
was calculated using the classical clearance forniula. Total and
renal cleararice s well s their difference (extrarenal clearance)
of both lipase and amylase were computed on the basis of the
formula for single injection technique (9). The results are related
to 100 g body weight.
Statistical analyses were carried out using the Student t test.
Mean vahies (x), Standard deviation (SD) and the number of
experinjents (n) are given. Differences between the half-life of
lipase and amylase in the same animal were determined using
the paired t test. The mean difference (d) and the corresponding
t "paired are given. Aiiy deviation was considered significant if
the requirement p < 0.05 was fulfilled.
Results
In figure l the decrease of lipase and amylase catalytic
activity in serum is shown in three patients with acute
pancreatitis. In all three cases there was no large
Variation in the apparent half-life of the enzymes
studied (shortest t V* lipase, 6.9 h: longest: amylase,
17.7h). In all patients amylase had a somewhat
longer t J/2 than lipase (by about 23%). Similar results
were obtained in two further patients (not shown
here).
Figure 2 shows the plasma lipase and amylase con-
centration of 28 patients with severe renal insuf-
ficiency. 15 of them had a higher than normal plasma
lipase concentration (left panel); the amylase con-
centration exceeded the upper limit of the normal
r nge in 10 cases (right panel). There was np correl-
ation between serum enzyme activity and serum crea-
tinine concentration.
The elimination rate of lipase and amylase from the
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Fig. 2. Serum lipase and amylase activity in relation to plasma
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Fig. 3. Elimination rate of lipase and amylase in rats with
normal renal function (o) and with ligated kidneys (o),
n = 4.
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with unimpaired renal function (füll dots) t!/2 of
lipase was 18.1 + 2.2 min, n = 4. It differed sig-
nificantly from that of amylase (20.5 + 2.0 min);
d = 2,4 min, t = 8.66. Regression coefficient (r)
was 0.99 in both cases. Open circles deinonstrate the
plasma enzyme activities in rats with ligated kidneys.
The slope of the regression lines of both lipase and
amylase differs significantly from those in animals
with functioning kidneys. The deviation is significant.
At the same time t % of lipase (55.6 + 9.2 min,
n = 4) was significantly shorter than t j/2 of amylase
(79.6 -l· 10.4 min); d = 24.3 min, t = 10.6.
Serum [14C]inulin radioactivity decreased according
to the first-order equation: In y = — 0.00236x +
4.584, r = 0.99. Half-life of [14C]inulin in control
rats was equal to 29.4 + 1.8 min (n = 4).
Figure 4 shows the urinary recovery of lipase and
amylase in two typical experiments. There was only
a little excretion of lipase during the first 40 min.
While the total excreted activity remained well below
5% of the injected activity, amylase was excreted
continuously by the kidneys up to 30% of the given
dose.
Table l contains the data of the clearance of lipase
and amylase. It is evident that the clearance of lipase
(total äs well äs renal) exceeded the clearance of
amylase significantly. The clearance of [14C]inulin was
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Tab. l. Clearance of lipase and amylase in the rat (ml/min
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Fig. 4. Urinary recovery of the injected lipase and amylase
activity in two rats. o = lipase; e = amylase.
Discussion
Our study demdnstrates that in cases of um
complicated, monophasic pancreatitis pancreatic
lipase and amylase disappear rapidly from the circuU
ation at approximately the same rate (fig. 1). The
elimination kinetics are first order, which implies that
in these patients a severe, but single and rather short-
lasting pathological event occured. It is probable that
the enzymes released into the circulätion in acute
pancreatic disorders enter the intravascular compart-
ment via the thoracic duct (10). Therefore, if the
period of enzyme release is short and the
peripancreatic lymphflow is unimpaired, the Situation
in patients is similar to our experimental design in
rats, i.e. to a bolus injection. The lowest t!/2 values
found for both enzymes (6.9 h for lipase and 9.3 h
for amylase — fig. 1) are distinctly lower than those
for most other clinically important enzymes. This
finding is relevant to the problem of clinical di-
agnosis; repeated checks ojf the lipase and amylase
activity of the serum make it possible to monitor
within hours whether or not the underlying path-
ological process still persists and what course the
disease takes. Thus, in uncomplicated, acute
pancreatitis, usually of the oedematous type, a rapid
fall of the serum activity can be expected. In diseases
with persisting tissue breakdown, e.g. alcoholic
(toxic) pancreatitis, an eventual initial rapid decline
would be followed by consistently high serum activ-
ities. It can therefore be cönelüded that a long-lasting
hyperlipasaemia is either due to progressive tissue
damage or to the development of pancreatic
pseudocysts. Gel filtration experiments showed no
indication for the presence of high molecular weight
forms of lipase in pancreatitis sera (own, unpublished
results), thus a delayed elimination caused by binding
of the enzyme to serum lipoproteins (11) seems not
to occur.
Our results show that the elevated levels of lipase,
amylase and creätinine in the serum of patients with
severe renal insufficiency (f^g. 2) are caused by a
J. Clin. Chein. Clin. Biochem. / Vol. 23,1985 / No. 7
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decreased GFR rather than by an increased enzyme
liberation from the pancreas due to an undefined
"uraemic pancreatitis", äs suggested by some authors
(12 — 14). In this context the lack of ariy correlation
between enzyme activity and creatinine concentration
of the serum is not surprising.
The clinical observation that lipase and amylase are
rapidly eliminated from the serum at nearly the same
rate is supported by our experimental data obtained
in rats (flg. 3). The small, but statistically significant
difference in the half-life of both enzymes cor-
responds to the difference between their respective
molecular weights (see above). The elimination shows
first order kinetics in both cases with no indication
for a biphasic course. The rate of renal elimination
of these enzymes from serum is fast. It greatly exceeds
even the summary effect of other possible factors that
would lead to a decline in serum activity (distribution
into other compartments, or degradation).
These results are in contrast to the basic concept on
the distribution of intravenously administered en-
zymes äs suggested by Friedel et al. (15). These
authors determined the elimination rates of several
enzymes of diagnostic importance. Their ex-
perimental design was similar to the methods used in
the present investigation. They found a linear, log-
log relationship between the rate of distribution into
the interstitial compartment and the molecular weight
of the enzymes studied. Introdücing the molecular
weights of lipase and amylase into their ex-
perimentally determined equation (In molecular
weight = 0.532 - In t1/! + 9.54) results in half-lives
insignificantly löwer than those determined by us:
10.3 and 13.3 min versus 18.2 and 20.5 min, re-
spectively. However, in animals with ligated kidneys
the half-lives were far longer than was expected from
the data of Friedel et al. (15), (fig. 4). This con-
tradiction can be explained by the fact that the dis-
tribution/elimination curve(s) proposed by the above
authors were obtained in animals with functioning
kidneys. Nevertiheless, they disregarded renal effects
in the elimination process. This might be acceptable
äs long äs only proteins with ä MT > 60000 are
concerned. It can certainly not be applied to filterable
mölecules in the ränge of size of lipase and amylase.
The excretion rate of both lipase and amylase
distinctly exceeded their respective distribution rate
(fig. 3, 4, tab. 1). Moreover, the elimination rate of
both enzymes was even larger than that of inulin.
The latter is completely filterable and diffuses into
the interstitial space readily. This indicates that with
normal kidney function an extravasal equilibrium will
not be achieved in practice for either enzyme (see
above). Thus, general formulas (15) for the calcula-
tion of distribution and/or elimination rates are help-
ful only if they are based on experiments carried out
on animals with ligated, äs well äs with functioning
kidneys. Evidence for the renal filtration of lipase, äs
well äs for albumin and ß2-microglobulin, has re-
cently been presented in an experiment in humans
after Inhibition of tubular reabsorption by lysine (16).
The different handling of lipase and amylase by the
kidney (fig. 4, tab. 1) is a further example for the
known selectivity of protein reabsorption in the renal
tubular System (17). Experimental data indicate that
the net Charge of proteins might be of importance
(18). However, these data were obtained with cationic
proteins, e. g. lysozyme and cytochrome c (19). There-
fore the idea that several proteins in the renal tubule
are absorbed to the negatively charged luminal
membrane is certainly attractive. On the other hand
the majority of filtered serum proteins, including
lipase and amylase, carry a negative net Charge at
physiological pH. Thus, the Charge factor is obviously
of minor significance. Since both enzymes have prac-
tically the same size and a similar net Charge (IP
for lipase = 5.8 (20); IP for the different forms of
amylase = 6.5 — 7.1 (21)) other or additional factors
must be responsible for the marked difference in the
extent of their tubular uptake. Differences in the
physicochemical properties of lipase and amylase
seem to us to be a more likely cause of their different
renal behaviour. Amylase has a high affinity towards
hydrophilic sites (starch, glycogen), whereas lipase
has a high affinity for hydrophobic surfaces or for
lipophilic-hydrophilic interfaces. Therefore, it is con-
ceivable that these different properties are relevant
to the binding and uptake by the luminal membrane.
However, äs yet no experimental data supporting this
idea can be presented.
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